NORTHEAST PHARMACEUTICAL GROUP CO., LTD.

Andere Sprachen Northeast Pharmaceutical Group Co., Ltd.

Aktien

000597

CNE0000009G0

000597

Schlusskurs Shenzhen S.E. Andere Börsenplätze 00:00:00 30.04.2024			% 5 Tage	% 1. Jan.
4,75 ^CNY	+1,93 %		+1,50 %	-11,21 %

25.04.	Northeast Pharmaceutical Group Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI
29.03.	Northeast Pharmaceutical Group Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25.04.
Northeast Pharmaceutical Group Co., Ltd. Proposes Profit Distribution for 2023	01.04.
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29.03.
Northeast Pharmaceutical's Levocarnitine Gets Nod to Enter EU Market	30.01.
Northeast Pharmaceutical's Piracetam Passes Generic Drug Evaluation in China	01.11.
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26.10.23
Northeast Pharmaceutical to Set Up Joint Venture With Muscat Changming Investments in Oman	20.09.23
Northeast Pharmaceutical Group Co., Ltd.(XSEC:000597) added to S&P Global BMI Index	18.09.23
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	22.08.23
Northeast Pharmaceutical Group Co., Ltd. Announces 2022 Final Cash Profit Distribution Plan, Payable on 16 May 2023	09.05.23
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27.04.23
Northeast Pharmaceutical Group Co., Ltd. Approves Final Cash Dividend for 2022	21.04.23
Northeast Pharmaceutical Group Co., Ltd. Proposes Final Cash Dividend for 2022	30.03.23
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	29.03.23
China Monthly Antitrust Update - March 2023	17.03.23
Northeast Pharma Appoints Former Bank Auditor as CFO	09.02.23
Northeast Pharmaceutical Unit Registers Anti-Seizure Drug in China	24.11.22
Northeast Pharmaceutical’s Piracetam Tablets Gets Regulatory Approval	10.11.22
Northeast Pharmaceutical Gets Supplementary Drug Application Approval For Tinidazole Tablets	01.11.22
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28.10.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Northeast Pharmaceutical Group Co., Ltd.

Aktien

000597

CNE0000009G0

000597

Andere Sprachen

Filter